Athersys, Cell Therapy Catapult deal

In January, Athersys and Cell Therapy Catapult partnered to evaluate Athersys’ MultiStem in a U.K. Phase IIa trial to treat acute respiratory distress syndrome (ARDS), which is expected to start next ...